250 related articles for article (PubMed ID: 24573676)
1. Tipin functions in the protection against topoisomerase I inhibitor.
Hosono Y; Abe T; Higuchi M; Kajii K; Sakuraba S; Tada S; Enomoto T; Seki M
J Biol Chem; 2014 Apr; 289(16):11374-11384. PubMed ID: 24573676
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
3. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes.
Regairaz M; Zhang YW; Fu H; Agama KK; Tata N; Agrawal S; Aladjem MI; Pommier Y
J Cell Biol; 2011 Nov; 195(5):739-49. PubMed ID: 22123861
[TBL] [Abstract][Full Text] [Related]
4. ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.
Jossé R; Martin SE; Guha R; Ormanoglu P; Pfister TD; Reaper PM; Barnes CS; Jones J; Charlton P; Pollard JR; Morris J; Doroshow JH; Pommier Y
Cancer Res; 2014 Dec; 74(23):6968-79. PubMed ID: 25269479
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I poisoning results in PARP-mediated replication fork reversal.
Ray Chaudhuri A; Hashimoto Y; Herrador R; Neelsen KJ; Fachinetti D; Bermejo R; Cocito A; Costanzo V; Lopes M
Nat Struct Mol Biol; 2012 Mar; 19(4):417-23. PubMed ID: 22388737
[TBL] [Abstract][Full Text] [Related]
7. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells.
Goldwasser F; Shimizu T; Jackman J; Hoki Y; O'Connor PM; Kohn KW; Pommier Y
Cancer Res; 1996 Oct; 56(19):4430-7. PubMed ID: 8813137
[TBL] [Abstract][Full Text] [Related]
8. Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion.
Leman AR; Noguchi C; Lee CY; Noguchi E
J Cell Sci; 2010 Mar; 123(Pt 5):660-70. PubMed ID: 20124417
[TBL] [Abstract][Full Text] [Related]
9. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage.
Adachi N; So S; Koyama H
J Biol Chem; 2004 Sep; 279(36):37343-8. PubMed ID: 15218034
[TBL] [Abstract][Full Text] [Related]
10. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement.
Unsal-Kaçmaz K; Chastain PD; Qu PP; Minoo P; Cordeiro-Stone M; Sancar A; Kaufmann WK
Mol Cell Biol; 2007 Apr; 27(8):3131-42. PubMed ID: 17296725
[TBL] [Abstract][Full Text] [Related]
11. Antisense transcripts enhanced by camptothecin at divergent CpG-island promoters associated with bursts of topoisomerase I-DNA cleavage complex and R-loop formation.
Marinello J; Chillemi G; Bueno S; Manzo SG; Capranico G
Nucleic Acids Res; 2013 Dec; 41(22):10110-23. PubMed ID: 23999093
[TBL] [Abstract][Full Text] [Related]
12. Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.
Lin CP; Ban Y; Lyu YL; Liu LF
J Biol Chem; 2009 Oct; 284(41):28084-28092. PubMed ID: 19666469
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition.
Nishida M; Terabayashi T; Matsuoka S; Okuma T; Adachi S; Tomo T; Kawano M; Tanaka K; Tsumura H; Anai H; Ishizaki T; Nishida Y; Hanada K
Commun Biol; 2022 Sep; 5(1):982. PubMed ID: 36114357
[TBL] [Abstract][Full Text] [Related]
14. Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.
Beidler DR; Cheng YC
Mol Pharmacol; 1995 May; 47(5):907-14. PubMed ID: 7538195
[TBL] [Abstract][Full Text] [Related]
15. Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition.
Berti M; Ray Chaudhuri A; Thangavel S; Gomathinayagam S; Kenig S; Vujanovic M; Odreman F; Glatter T; Graziano S; Mendoza-Maldonado R; Marino F; Lucic B; Biasin V; Gstaiger M; Aebersold R; Sidorova JM; Monnat RJ; Lopes M; Vindigni A
Nat Struct Mol Biol; 2013 Mar; 20(3):347-54. PubMed ID: 23396353
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin.
Desai SD; Liu LF; Vazquez-Abad D; D'Arpa P
J Biol Chem; 1997 Sep; 272(39):24159-64. PubMed ID: 9305865
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
Desai SD; Li TK; Rodriguez-Bauman A; Rubin EH; Liu LF
Cancer Res; 2001 Aug; 61(15):5926-32. PubMed ID: 11479235
[TBL] [Abstract][Full Text] [Related]
18. Cullin 3 promotes proteasomal degradation of the topoisomerase I-DNA covalent complex.
Zhang HF; Tomida A; Koshimizu R; Ogiso Y; Lei S; Tsuruo T
Cancer Res; 2004 Feb; 64(3):1114-21. PubMed ID: 14871846
[TBL] [Abstract][Full Text] [Related]
19. Separation of intra-S checkpoint protein contributions to DNA replication fork protection and genomic stability in normal human fibroblasts.
Smith-Roe SL; Patel SS; Zhou Y; Simpson DA; Rao S; Ibrahim JG; Cordeiro-Stone M; Kaufmann WK
Cell Cycle; 2013 Jan; 12(2):332-45. PubMed ID: 23255133
[TBL] [Abstract][Full Text] [Related]
20. New Topoisomerase I mutations are associated with resistance to camptothecin.
Gongora C; Vezzio-Vie N; Tuduri S; Denis V; Causse A; Auzanneau C; Collod-Beroud G; Coquelle A; Pasero P; Pourquier P; Martineau P; Del Rio M
Mol Cancer; 2011 May; 10():64. PubMed ID: 21619602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
